India's first registry of childhood cancer survivors shows a 94.5 per cent rate of five-year overall survival and nearly 90 per cent event-free survival, according to a study published in The Lancet Regional Health Southeast Asia journal. The Indian Childhood Cancer Survivorship (C2S) study, initiated in 2016, is among the world's first registry from a resource-limited setting, researchers said. The team, including researchers from the All India Institute of Medical Sciences (AIIMS) and Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, looked at 5,419 children diagnosed with cancer before turning age 18 and in remission post-treatment from 20 centres across the country. Survival data was available for 5,140 participants. Acute leukaemia was found to be the most common diagnosis (40.9 per cent), while common therapeutic strategies included chemotherapy for 94.7 per cent of the participants, surgery for 30 per cent and radiotherapy for 26.3 per cent. "The 5-year overall .
A sperm donor unknowingly carrying a rare cancer-causing gene mutation fathered 67 children in Europe, with 10 diagnosed with cancer already, prompting urgent calls for limits on use of donor sperm
The study has found that the environment plays a statistically significant role in outcomes of cancers like acute leukaemia which need intensive treatment
While there is strong evidence for the benefits of proton therapy in children, it is much less clear in prostate and other adult cancers.
Cardiovascular disease was found in 4.5% of survivors and occurred in the majority before they reached the age of 40